Aindra Systems
At Aindra, we are building a world where Clinical Pathology is Data driven, Fast and Patient focused. Aindra Systems, our goal is to democratise access to quality healthcare, by using deep technology to realise our vision of accessible and affordable healthcare solutions. As technology enthusiasts, we believe the impact of leveraging technologies like Artificial Intelligence in the right way, can deliver more smarter, quicker and reliable systems that will help overcome the existing challenges of the healthcare system.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Nationally (across the country)
About Us
Why? 5.8 billion people. That is the number of people on the planet who today, do not have access to a reliable and high quality healthcare. While inaccessibility is the problem facing the developing world, expensive machines and treatment methods are driving healthcare costs uncomfortably high in the developed countries. And we want to change this broken healthcare system.
We at Aindra, are a passionate bunch of technophiles. We’re trying to converge the best technologies to make healthcare more accessible and affordable, as it’s supposed to be. ‘Affordable healthcare solutions for all’ is our ethos.
How? At, Aindra Systems, our goal is to democratise access to quality healthcare, by using deep technology to realise our vision of accessible and affordable healthcare solutions.
As technology enthusiasts, we believe the impact of leveraging technologies like Artificial Intelligence in the right way, can deliver more smarter, quicker and reliable systems that will help overcome the existing challenges of the healthcare system.
What? Our AI platform Astra, is built to detect critical illnesses such as Cancer. Astra is a powerful platform that can be extended to build detection tools for a number of critical illnesses.
As the first beachhead, we have developed a point-of-care detection system for Cervical Cancer that is quick, affordable and accessible. CervAstra will enable women to walk-in to their nearest primary health center, get screened and walk out with their reports. It is that simple.
Our intelligent screening system CervAstra, tailwinds the development and striking benefits of computational pathology.
As a for-profit social enterprise, Aindra commits to reinvest a part of our profits to further our social mission.
Our Technology
Faster diagnosis
Why AI? The biggest reason is because today, multiple factors have converged to create an environment where AI can make discoveries and judgments leading to faster and more accurate diagnoses than humans can perform. It significantly reduces the turnaround time for reports and also enables pathologists to look at only the relevant data.
Farther Outreach
Healthcare Inclusion. Diagnostic centers are concentrated in the larger cities, whereas most of the population resides in smaller cities or villages. Our compact systems are portable that can be carried to the point- of care. Our technology enables the healthcare system to extend itself into the far reaches of any country.
Increased Throughput
Fatigued and limited pathologists, cause a delay in reports, and increase the number of misdiagnoses leading to enormous social & economic costs. There is also an shortage of specialists at many medical institutions. There is a need for an AI imaging diagnosis support system that can interpret images, detect small lesions that even specialists could miss. AI eliminates the grunt work of looking at 80% normal samples.
Feedback Learning
Through intelligent architecting of the system, the AI algorithms are continuously learning from human intervention when Pathologists either confirm or reject the findings of the algorithms. These are then automatically redirected back as feedback, to build even better Deep Learning models. If data is the life blood of any Deep Learning system, our system ensures that there is a constant supply of supervised data that goes into building better models.
Solutions
One woman dies every 2 minutes globally due to Cervical Cancer. Currently, there exists no reliable, smart and fast solution for the screening of Cervical Cancer in all developing nations. Although cervical cancer has a higher gestation period, due to lack of affordable and accessible screening tests, the count of women detected with Cervical Cancer is rising and so is the mortality.
CervAstra, our first product to detect Cervical Cancer is built using ASTRA, our Computational Pathology platform. CervAstra analyzes pap smear samples at the Point-of-Care to call out Normal or Abnormal all in under a few hours as opposed to a larger turnaround time of a few weeks depending on the location of sample collection.